查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197355

關節重建設備市場-增長、趨勢和預測 (2023-2028)

Joint Reconstruction Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，聯合重建設備市場預計將以 6.55% 的複合年增長率註冊。

由於擇期手術的取消，COVID-19 正在影響關節重建設備市場。 例如，2021 年 4 月發表在 J.Arthroplasty 上的一篇文章報導說，COVID-19 大流行對關節成形術實踐產生了重大影響。 該論文還報告說，大流行期間發生了許多髖關節和膝關節置換術取消，直接影響了關節重建設備市場。 因此，初期市場受疫情制約，面臨較大困難。 然而，隨著政府限制的放鬆和醫療服務的重新開放，該市場經歷了顯著增長。

推動這一市場增長的主要因素是骨科疾病患病率增加、人口老齡化加劇、對微創技術的偏好增加、大型關節重建手術數量增加等。 隨著關節炎、骨質疏鬆、膝關節損傷等骨科疾病患病率的增加，導致嚴重的骨損傷，關節重建手術已成為最終的治療手段。 例如，英國 2021 年 12 月發布的與工作相關的肌肉骨骼疾病統計數據估計，2020/21 年將有 470 萬工人患有與工作相關的肌肉骨骼疾病（新的或長期的）。據報導， 這相當於每 100,000 名工人中有 1,420 例，因此佔所有與工作有關的疾病的 28%。

同樣，2021 年 1 月發表在 PTJ 上的另一篇論文報告說，在美國，肌肉骨骼疾病是與日常生活和獲得報酬相關的殘疾和限制的最常見原因。我在這裡。 因此，膝蓋和臀部等肌肉骨骼疾病的流行增加了對關節置換手術的需求。 這正在推動市場的增長。

隨著老年人口的增加，骨骼脆弱的可能性增加，因此預計研究的市場也會增長。 老年人更容易患關節相關疾病，因此需要進行關節重建手術，這推動了關節重建設備的市場。 例如，2022 年 1 月發表在《J. Am. Acad. Orthop. Surg》雜誌上的一篇論文。推動市場的增長。

此外，微創手術的引入（疼痛更輕、住院時間更短、並發症更少）以及這種手術方法的廣泛使用都有助於關節置換設備市場的增長。 例如，2022 年 5 月，富裡總理報告了一種解決髖關節和膝關節置換手術積壓問題的新方法。 通過改進圍手術期短效麻醉、微創手術技術和術後立即啟動康復方案，它也可以作為門診手術。 因此，技術進步進一步推動了市場的增長。

此外，大型關節重建手術的增加也推動了所研究市場的增長。 例如，2021 年 11 月，美國骨科醫師學會的分支機構 AJRR 在其 2021 年髖關節和膝關節置換術手術趨勢年度報告中宣布，與上一年（2020 年）相比，累計手術總數有所增加。報告增長了 18.3%。 因此，聯合重建手術的增加正在推動所研究市場的增長。

因此，由於上述原因，預計市場在預測期內將出現顯著增長。 然而，由於對替代療法的認識不斷提高，嚴格的監管改革和監管問題可能會阻礙所研究市場的增長。

關節重建設備的市場趨勢

關節置換設備領域預計在預測期內顯著增長

由於老年人口的增加、膝關節退行性疾病的增加以及技術的發展，預計關節置換設備部分在預測期內將出現顯著增長。

全球關節置換手術的增加促進了這一領域的發展。 例如，發表在 J. Orthop. Surg. Res. 雜誌上的一篇論文預計到 2030 年將增長 673%。因此，對關節置換手術的高需求正在推動該行業的增長。

同樣，全球日益老齡化的人口也在推動這一細分市場的增長。 由於老年人口在關節手術中更為普遍，他們不斷增加的人口預計將推動研究市場的增長。 例如，聯合國 2022 概況報導稱，到 2022 年，世界上約有 9.7% 的人口將超過 65 歲，而這一數字預計到 2050 年將增加 16.4%。 因此，大量老齡化人口正在推動這一細分市場的增長。

醫療設備的安全性和有效性、產品發布、併購以及合作夥伴關係等技術進步正在推動這一細分市場的增長。 例如，2022 年 7 月，Enovis 推出了一款用於膝關節和髖關節置換手術的可穿戴設備。 該系統是唯一專有的實時、免提增強現實 (AR) 技術，旨在為骨科醫生進行髖關節和膝關節手術時提供精確的可視化指導。據說。 同樣，2022 年 4 月，印度一家醫院將引進 CUVIS 第 3 代主動式全自動關節置換系統。 因此，此類技術進步正在推動該細分市場的增長。

因此，由於上述原因，預計該部分在預測期內將出現重大變化。

預計在預測期內北美將顯著增長

由於手術數量的增加、骨科疾病日益增多的老齡化社會的到來以及對微創手術的偏好，預計北美在預測期內將出現顯著增長。

該地區越來越多的關節手術正在推動市場的增長。 例如，2022 年 2 月發表在《今日關節成形術》(Arthroplasty Today) 上的一篇文章報導，AJRR 2021 在過去十年中佔了 2,244,587 例初次和翻修髖關節和膝關節置換術。 大多數手術是全膝關節置換術（54.5%）和全髖關節置換術（38.6%）。 女性患者佔所有手術的58.5%，男性患者佔38.6%。 該論文報告稱，與往年相比，這些手術數量顯著增加。 老年人更有可能接受這些手術。 因此，大量的關節置換手術正在推動該地區該市場的增長。

由於人口老齡化和技術發展，北美的另外兩個國家加拿大和墨西哥也在推動市場增長。 2022 年 4 月，加拿大統計局報告稱，該國 65 歲及以上的人口有 730 萬。 85 歲以上的人口在過去六年中也增長了 12%，成為增長最快的年齡組之一。 因此，不斷增長的老年人口導致關節重建手術的增加，這是推動該地區市場研究的一個因素。

主要市場參與者的技術進步正在推動該地區該市場的增長。 例如，2022 年 10 月，Orthofix 和 SeaSpine 對等合併，組成一家全球脊柱和骨科公司。 合併後的公司將成為一家全球脊柱和骨科公司。 它將擁有高度互補的生物製劑、創新脊柱硬件、骨骼生長療法、骨科專業解決方案和手術導航系統的產品組合。

因此，由於上述因素，預計該地區在預測期內將出現顯著增長。

關節重建設備市場競爭對手分析

關節重建設備市場由許多區域和全球參與者主導，包括 B. Braun GmbH (Aesculap Implant Systems LLC)、Conmed Corporation、Johnson and Johnson (DePuy Synthes Inc.) 和 Donjoy Inc。存在市場參與者的增多導致了一個分散且競爭激烈的市場。 區域和全球合作夥伴，例如 Supply and Services Inc.、Medtronic Inc.、Nuvasive Inc.、Smith & Nephew PLC、Stryker Corporation、Wright Medical Technology Inc、Zimmer Biomet Holdings Inc、AAP Implantate AG、Allegra Orthopedics Limited、Alphatec Spine Inc.包括位於

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 骨科疾病增加
    • 人口老齡化加劇
    • 越來越喜歡微創技術
    • 大關節重建手術增加
  • 市場製約因素
    • 對替代療法的認識不斷提高
    • 嚴格的監管改革
    • 監管問題
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按設備類型
    • 關節置換裝置
    • 截骨裝置
    • 關節鏡設備
    • 重鋪設備
    • 人工關節置換設備
    • 其他設備
  • 按關節類型
    • 膝關節
    • 髖關節
    • 肩關節
    • 腳踝
    • 其他關節
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • B. Braun GmbH（Aesculap Implant Systems LLC）
    • Conmed Corporation
    • Johnson and Johnson（DePuy Synthes Inc.）
    • Donjoy Inc. Supply and Services Inc.
    • Medtronic Inc.
    • Nuvasive Inc.
    • Smith & Nephew PLC
    • Stryker Corporation
    • Wright Medical Technology Inc.
    • Zimmer Biomet Holdings Inc.
    • AAP Implantate AG
    • Allegra Orthopaedics Limited
    • Alphatec Spine Inc.

第7章 市場機會與今後動向

簡介目錄
Product Code: 66062

The joint reconstruction devices market is expected to witness a CAGR of 6.55% during the forecast period.

COVID-19 had impacted the joint reconstruction devices market due to the cancellation of elective surgeries. For instance, an article published in J. Arthroplasty in April 2021 reported that the COVID-19 pandemic significantly affected arthroplasty practice. The article also reported the cancellation of many hip and knee arthroplasty services during the pandemic, which directly impacted the joint reconstruction devices market. Thus, initially, the market faced significant challenges due to the pandemic restrictions. However, with the ease of government regulations and the resumption of healthcare services the market witnessed significant growth.

The key factors propelling the growth of the market studied are the growing prevalence of orthopedic diseases, the increasing aging population, the increasing preference for minimally invasive techniques, and an increasing number of large joint reconstruction surgeries. With the growing prevalence of orthopedic diseases such as arthritis, osteoporosis, knee injuries, etc., resulting in damage to bones and serious cases, joint reconstruction surgery is the ultimate treatment available. For instance, in December 2021, Work-Related Musculoskeletal Disorders Statistics in Great Britain reported that 4,70,000 workers suffered from work-related musculoskeletal disorders (new or long-standing) in 2020/21. This represents 1,420 per 100,000 workers and thus accounts for 28% of all work-induced ill health.

Similarly, another article published by the journal PTJ in January 2021 reported that musculoskeletal conditions are the most common causes of disability and limitations related to daily living and gainful employment in the United States. Thus, a high number of musculoskeletal conditions, including knee, hip, and other joint conditions, increase the demand for joint replacement surgical procedures. This is propelling the market's growth.

As the geriatric population increases, the market studied is also expected to grow as weak bones are more likely to develop in the geriatric population. Joint-related disorders are more likely to arise in the geriatric population, resulting in the need for joint reconstruction surgery, thereby driving the market for joint reconstruction devices. For instance, an article published in the journal, J. Am. Acad. Orthop. Surg. in January 2022 reported a higher prevalence of joint pain among the older population. Thus, with increasing aging, individuals become more susceptible to orthopedic diseases, leading to increasing joint surgery, thereby driving the growth of the market studied.

Also, the introduction of minimally invasive surgery, which is associated with less pain, a shorter hospital stay, and fewer complications, and the increasing use of this surgical procedure are contributing to the growth of the joint replacement devices market. For instance, in May 2022, Premier Furey reported a new approach to address surgical backlogs for hip and knee replacement surgeries. Also, improved perioperative short-acting anesthesia, minimally invasive surgical techniques, and the initiation of rehabilitation protocols soon after surgery have made this surgery possible as an outpatient procedure. As a result, technological advancements are further propelling the growth of the market studied.

Furthermore, the increasing number of large joint reconstruction surgeries is also propelling the growth of the studied market. For instance, in November 2021, the AJRR, the cornerstone of the American Academy of Orthopaedic Surgeons in its 2021 Annual Report on hip and knee arthroplasty procedural trends, reported an overall cumulative procedural volume growth of 18.3% compared to the previous year, 2020. Thus, the increasing number of joint reconstruction surgeries is driving the growth of the market studied.

Thus, for the aforesaid reasons, the market is expected to witness significant growth during the forecast period. However, due to increased awareness about alternative treatments, stringent regulatory reforms and regulatory issues may hamper the growth of the market studied.

Joint Reconstruction Devices Market Trends

Joint Replacement Devices Segment is Expected to Witness a Significant Growth Over the Forecast Period.

The joint replacement devices segment is expected to witness significant growth over the forecast period owing to the increase in the geriatric population, the increase in degenerative knee diseases, and technological developments.

The increasing number of joint replacement surgery occurring globally is contributing to the growth of this segment. For instance, an article published in the journal, J. Orthop. Surg. Res., in October 2022, reported a significant increase in the number of osteosynthesis implants and joint replacement implants in the past decade, and the demand for knee replacement in the United States is expected to increase by 673% by 2030. Thus, the high demand for joint replacement surgery is propelling the growth of this segment.

Similarly, the increasing geriatric population globally is also propelling the growth of this segment, as the geriatric population is more prevalent in joint surgeries and the increasing their increasing population is expected to drive the growth of the studied market. For instance, United Nations 2022, factsheet reported that in 2022, about 9.7% population in the world aged 65 and above, and this number is expected to increase by 16.4% by 2050. Thus, the high geriatric population is propelling the growth of this segment.

The safety and efficacy of medical devices and technological advancements such as product launches, mergers, acquisitions, and partnerships are propelling the growth of this segment. For instance, in July 2022, Enovis launched a wearable device for knee and hip replacement. The system is said to be the only proprietary, real-time, hands-free augmented reality (AR) technology that has been developed to provide orthopedic surgeons with precision guidance visualization while performing hip and knee surgery. Similarly, in April 2022, a joint replacement device CUVIS third generation active and fully automated joint replacement system in one of the hospitals in India. Thus, such technological advancements is driving the growth of the segment.

Thus, due to the aforesaid reasons, the segment is expected to witness a significant over the forecast period.

North America is Expected to Witness a Significant Growth Over the Forecast Period

North America is expected to witness significant growth during the forecast period due to the increasing number of surgeries, the rising aging population with increasing orthopedic conditions, and the preference toward minimally invasive procedures.

The increasing number of joint surgeries in the region is propelling the growth of this market in the region. For instance, an article published in Arthroplasty Today in February 2022 reported that the AJRR 2021 accounted for 2,244,587 primary and revision hip and knee arthroplasties in the last decade. Most of the surgeries were primary total knee arthroplasty (54.5%) and primary total hip arthroplasty (38.6%). Female patients represented 58.5% of all procedures, while male patients represented 38.6% of all cases. The article reported a significant increase in these surgeries as compared to previous years. A high percentage of the geriatric population undergoes these surgical procedures. Thus, a high number of joint replacement surgical procedures is driving the growth of this market in the region.

The other two North American countries, Canada and Mexico, are also propelling the growth of the market owing to the increase in the geriatric population and technological development. In April 2022, Statistics Canada reported that there were 7.3 million people aged 65 and older in the country. Also, the population aged 85 and older is one of the fastest-growing age groups, with a 12% increase in the last six years. Thus, an increasing geriatric population is associated with an increase in joint reconstruction surgery, thereby propelling the market studied in the region.

Technological advancements by key market players are propelling the growth of this market in the region. For instance, in October 2022, Orthofix and SeaSpine combined in a merger of equals to create a global spine and orthopedics company. The combined company will be a global spine and orthopedics company. It will have highly complementary portfolios of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a surgical navigation system.

Thus, due to the above-mentioned factors, the region is expected to witness significant growth during the forecast period.

Joint Reconstruction Devices Market Competitor Analysis

The joint reconstruction devices market is fragmented and competitive due to the presence of many market players present regionally and globally such as B. Braun GmbH (Aesculap Implant Systems LLC), Conmed Corporation, Johnson and Johnson (DePuy Synthes Inc.), Donjoy Inc. Supply and Services Inc., Medtronic Inc., Nuvasive Inc., Smith & Nephew PLC, Stryker Corporation, Wright Medical Technology Inc., Zimmer Biomet Holdings Inc., AAP Implantate AG, Allegra Orthopaedics Limited, and Alphatec Spine Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Orthopedic Diseases
    • 4.2.2 Increasing Aging Population
    • 4.2.3 Increasing Preference for Minimally Invasive Techniques
    • 4.2.4 Increasing Number of Large Joint Reconstruction Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Increase Awareness about Alternative Treatments
    • 4.3.2 Stringent Regulatory Reforms
    • 4.3.3 Regulatory Issues
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Device Type
    • 5.1.1 Joint Replacement Devices
    • 5.1.2 Osteotomy Devices
    • 5.1.3 Arthroscopy Devices
    • 5.1.4 Resurfacing Devices
    • 5.1.5 Arthrodesis Devices
    • 5.1.6 Other Device Types
  • 5.2 By Joint Type
    • 5.2.1 Knee
    • 5.2.2 Hip
    • 5.2.3 Shoulder
    • 5.2.4 Ankle
    • 5.2.5 Other Joint Types
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun GmbH (Aesculap Implant Systems LLC)
    • 6.1.2 Conmed Corporation
    • 6.1.3 Johnson and Johnson (DePuy Synthes Inc.)
    • 6.1.4 Donjoy Inc. Supply and Services Inc.
    • 6.1.5 Medtronic Inc.
    • 6.1.6 Nuvasive Inc.
    • 6.1.7 Smith & Nephew PLC
    • 6.1.8 Stryker Corporation
    • 6.1.9 Wright Medical Technology Inc.
    • 6.1.10 Zimmer Biomet Holdings Inc.
    • 6.1.11 AAP Implantate AG
    • 6.1.12 Allegra Orthopaedics Limited
    • 6.1.13 Alphatec Spine Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS